The effectiveness of unified transdiagnostic treatment on body dysmorphic disorder comorbid with emotional disorders

The effectiveness of unified transdiagnostic treatment on emotional, cognitive, and neuropsychological symptoms and indicators in individuals with body dysmorphic disorder comorbid with emotional disorders: A clinical trial study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20231001059577N1

Enrollment

Registered

2024-01-18

Start date

2024-01-25

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

body dysmorphic disorder comorbid with emotional disorders. Body dysmorphic disorder

Interventions

Intervention 1: Intervention group: group 1: UP group. Unified protocol for transdiagnostic of emotional disorders consists of a maximum of 10, 45-minute individual treatment sessions. The UP targets

identifying emotion-driven behaviors (EDBs) and replacing them with adaptive behaviors

identifying and preventing patterns of emotion avoidance

increasing awareness and confronting physical sensations, and facing emotions in situations. The treatment is preceded by enhancing the motivation and readiness of individuals for change and treatment

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Diagnosis of BDD disorder according to DSM-5 Having a minimum score of 53 in the body image concern inventory of Littleton et al The presence of at least one emotional disorder Age range of people from 18 to 45 years Willing to participate in the study by signing a written consent form The ability to speak Persian in all assessments Not having serious mental disorders such as psychosis, bipolar type I or II Not having suicidal thoughts No abuse of benzodiazepines, antipsychotics, and SSRI medicines in the last 6 months

Exclusion criteria

Exclusion criteria: Need for medical intervention Receiving psychotherapy sessions at the same time Concerns about weight-related eating disorders Unwillingness to continue participating at any time in the study Absence of more than 3 sessions in treatment sessions

Design outcomes

Primary

Measure	Time frame
Score of Body Image Concern from BICI questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Body Image Concern Inventory.;Score of depression and Anxiety from DASS-21 questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: DASS-21 questionnaire.	—

Secondary

Measure	Time frame
Score of cognitive fusion from CFQ. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: CFQ questionnaire.;Score of cognitive emotion regulation from CERQ. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: CERQ questionnaire.;Score of cognitive avoidance from CAQ. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: CAQ questionnaire.;Score of difficulties in emotion regulation from DERS. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: DERS questionnare.;Score of anxiety sensitivity from ASI. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: ASI questionnaire.;Score of Problem-solving from Tower of London. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Tower of London software.;Score of inhibition from go/no go test. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Go/no go software.;Score of working memory from n-back test. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: N- back software.	—

Measure

Time frame

Score of cognitive fusion from CFQ. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: CFQ questionnaire.;Score of cognitive emotion regulation from CERQ. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: CERQ questionnaire.;Score of cognitive avoidance from CAQ. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: CAQ questionnaire.;Score of difficulties in emotion regulation from DERS. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: DERS questionnare.;Score of anxiety sensitivity from ASI. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: ASI questionnaire.;Score of Problem-solving from Tower of London. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Tower of London software.;Score of inhibition from go/no go test. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Go/no go software.;Score of working memory from n-back test. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: N- back software.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Etaati

University of Kurdistan

fateme.etaati@uok.ac.ir087-33664600-8

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026